Dutch medicines agency head Aginus Kalis to move on
This article was originally published in Scrip
Executive Summary
Aginus Kalis, a key figure in the EU pharmaceutical regulatory network, is to leave his post as executive director of the Dutch Medicines Evaluation Board on 1 February next year, after 10 years in the role.